325 related articles for article (PubMed ID: 22370556)
1. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.
Li C; Xing L; Che S
Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556
[TBL] [Abstract][Full Text] [Related]
2. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
[TBL] [Abstract][Full Text] [Related]
3. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
5. A facile approach for crosslinker free nano self assembly of protein for anti-tumor drug delivery: factors' optimization, characterization and in vitro evaluation.
Asghar S; Salmani JM; Hassan W; Xie Y; Meng F; Su Z; Sun M; Xiao Y; Ping Q
Eur J Pharm Sci; 2014 Oct; 63():53-62. PubMed ID: 25004412
[TBL] [Abstract][Full Text] [Related]
6. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive supramolecular vesicles based on water-soluble pillar[6]arene and ferrocene derivative for drug delivery.
Duan Q; Cao Y; Li Y; Hu X; Xiao T; Lin C; Pan Y; Wang L
J Am Chem Soc; 2013 Jul; 135(28):10542-9. PubMed ID: 23795864
[TBL] [Abstract][Full Text] [Related]
8. pH-responsive hybrid magnetic polyelectrolyte complex based on alginate/BSA as efficient nanocarrier for curcumin encapsulation and delivery.
Amani S; Mohamadnia Z; Mahdavi A
Int J Biol Macromol; 2019 Dec; 141():1258-1270. PubMed ID: 31518625
[TBL] [Abstract][Full Text] [Related]
9. Attachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cells.
Kouchakzadeh H; Shojaosadati SA; Mohammadnejad J; Paknejad M; Rasaee MJ
Hum Antibodies; 2012; 21(3-4):49-56. PubMed ID: 23549021
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.
Martínez A; Benito-Miguel M; Iglesias I; Teijón JM; Blanco MD
J Biomed Mater Res A; 2012 Jun; 100(6):1467-76. PubMed ID: 22396108
[TBL] [Abstract][Full Text] [Related]
11. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
[TBL] [Abstract][Full Text] [Related]
12. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
13. pH and reduction dual-bioresponsive polymersomes for efficient intracellular protein delivery.
Zhang J; Wu L; Meng F; Wang Z; Deng C; Liu H; Zhong Z
Langmuir; 2012 Jan; 28(4):2056-65. PubMed ID: 22188099
[TBL] [Abstract][Full Text] [Related]
14. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
15. Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.
Zhang JY; He B; Qu W; Cui Z; Wang YB; Zhang H; Wang JC; Zhang Q
J Microencapsul; 2011; 28(6):528-36. PubMed ID: 21702701
[TBL] [Abstract][Full Text] [Related]
16. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release.
Yang Z; Zhang N; Ma T; Liu L; Zhao L; Xie H
Drug Deliv; 2020 Dec; 27(1):1156-1164. PubMed ID: 32755291
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
18. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X
Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
20. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]